These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31593759)
1. In Vitro Benchmarking Study of Ventricular Assist Devices in Current Clinical Use. Radley G; Pieper IL; Robinson CR; Ali S; Beshr M; Bodger O; Thornton CA J Card Fail; 2020 Jan; 26(1):70-79. PubMed ID: 31593759 [TBL] [Abstract][Full Text] [Related]
2. The CentriMag centrifugal blood pump as a benchmark for in vitro testing of hemocompatibility in implantable ventricular assist devices. Chan CH; Pieper IL; Hambly R; Radley G; Jones A; Friedmann Y; Hawkins KM; Westaby S; Foster G; Thornton CA Artif Organs; 2015 Feb; 39(2):93-101. PubMed ID: 25066768 [TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of the hemocompatibility of two centrifugal left ventricular assist devices. Zayat R; Moza A; Grottke O; Grzanna T; Fechter T; Motomura T; Schmidt-Mewes C; Breuer T; Autschbach R; Rossaint R; Goetzenich A; Bleilevens C J Thorac Cardiovasc Surg; 2019 Feb; 157(2):591-599.e4. PubMed ID: 30414772 [TBL] [Abstract][Full Text] [Related]
5. A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility. Bartoli CR; Hennessy-Strahs S; Gohean J; Villeda M; Larson E; Longoria R; Kurusz M; Acker MA; Smalling R Ann Thorac Surg; 2019 Jun; 107(6):1761-1767. PubMed ID: 30586577 [TBL] [Abstract][Full Text] [Related]
6. Numerical Analysis of Blood Damage Potential of the HeartMate II and HeartWare HVAD Rotary Blood Pumps. Thamsen B; Blümel B; Schaller J; Paschereit CO; Affeld K; Goubergrits L; Kertzscher U Artif Organs; 2015 Aug; 39(8):651-9. PubMed ID: 26234447 [TBL] [Abstract][Full Text] [Related]
7. Ovine Leukocyte Microparticles Generated by the CentriMag Ventricular Assist Device In Vitro. Pieper IL; Radley G; Christen A; Ali S; Bodger O; Thornton CA Artif Organs; 2018 Jun; 42(6):E78-E89. PubMed ID: 29512167 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding. Bartoli CR; Kang J; Restle DJ; Zhang DM; Shabahang C; Acker MA; Atluri P JACC Heart Fail; 2015 Nov; 3(11):860-9. PubMed ID: 26454844 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of von Willebrand factor profiles after implantation of left ventricular assist device and total artificial heart. Reich HJ; Morgan J; Arabia F; Czer L; Moriguchi J; Ramzy D; Esmailian F; Lam L; Dunhill J; Volod O J Thromb Haemost; 2017 Aug; 15(8):1620-1624. PubMed ID: 28586149 [TBL] [Abstract][Full Text] [Related]
10. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices. Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734 [TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device. Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921 [TBL] [Abstract][Full Text] [Related]
12. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System. Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422 [TBL] [Abstract][Full Text] [Related]
13. In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study. Chan CHH; Diab S; Moody K; Frazier OH; Sampaio LC; Fraser CD; Teruya J; Adachi I Artif Organs; 2018 Nov; 42(11):1028-1034. PubMed ID: 30101559 [TBL] [Abstract][Full Text] [Related]
14. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation. Kang J; Zhang DM; Restle DJ; Kallel F; Acker MA; Atluri P; Bartoli CR J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1747-1754.e1. PubMed ID: 26971377 [TBL] [Abstract][Full Text] [Related]